Target intelligence / Profile preview

Eustachian tube (ET)

Target
ET
Molecular classification
Other
01

Overview

The Eustachian tube is a fibrocartilaginous and osseous duct that connects the middle ear to the nasopharynx, playing a critical role in maintaining middle ear homeostasis. Its primary biological functions include equalizing air pressure between the middle ear and the atmosphere, draining mucociliary secretions from the middle ear into the nasopharynx, and protecting the middle ear from nasopharyngeal pathogens and loud sounds. Normally closed, the tube opens during activities such as swallowing, yawning, or chewing through the action of peritubal muscles like the tensor veli palatini and levator veli palatini. Dysfunction of the Eustachian tube (ETD) occurs when the tube fails to open or close properly, often due to inflammation, mucosal edema, or anatomical obstructions caused by allergies, upper respiratory infections, or gastroesophageal reflux. This can lead to negative middle ear pressure, fluid accumulation (otitis media), and hearing loss. While the Eustachian tube is an anatomical structure rather than a molecular target, pharmaceutical interventions typically address the underlying mucosal inflammation or congestion. Drugs such as nasal corticosteroids (e.g., fluticasone) and decongestants (e.g., oxymetazoline) are used to reduce swelling around the tubal orifice, thereby indirectly restoring its patency and function.

Other names
Auditory tubePharyngotympanic tubeOtopharyngeal tubeEustachian duct
02

Mechanism of action

Alpha-adrenergic receptor agonist, Glucocorticoid receptor agonist, Histamine H1 receptor antagonist

03

Biological functions

Other
04

Disease associations

InfectionInflammationOther
05

Safety considerations

Rebound congestion (rhinitis medicamentosa) from prolonged topical decongestant useSystemic cardiovascular effects from oral decongestants (e.g., hypertension, tachycardia)Failure of medical therapy necessitating surgical intervention (e.g., balloon dilation, tympanostomy tubes)
06

Interacting drugs

Oxymetazoline

5 more in the full profile.

07

Biomarkers

TympanometryEustachian Tube Dysfunction Questionnaire (ETDQ-7)Wideband absorbance

Beyond the preview

Go deeper on Eustachian tube (ET).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eustachian tube (ET).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call